← FDA Drug Approvals (Drugs@FDA)
OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TORRENT · Approved 2016-10-26
Drug application
- FDA Application #
ANDA203580- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE
- Generic name
- Amlodipine Besylate
- Active ingredients
- AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- TORRENT
- First approval
- 2016-10-26
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown